Correction to: The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1 (Breast Cancer Research and Treatment, (2015), 150, 1, (105-118), 10.1007/s10549-015-3298-2);The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1

Breast Cancer Research and Treatment

Volumn 150, Issue 1, 2015, Pages 105-118

  Zheng, Lufeng ^a   Li, Xiaoman ^a   Gu, Yi ^a   Lv, Xiaobo ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

3 UTR; Breast cancer; ceRNA; CYP4Z2P; Pseudogene

Indexed keywords

CYTOCHROME P450; DICER; MICRORNA; MICRORNA 1226; MICRORNA 125A 3P; MICRORNA 197; MICRORNA 204; MICRORNA 211; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN A; 3' UNTRANSLATED REGION; CYP4Z1 PROTEIN, HUMAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOINFORMATICS; BREAST CANCER; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYP4Z1 GENE; CYP4Z2P PSEUDOGENE; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; GENE; GENE EXPRESSION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; RNA INTERFERENCE; RNA TRANSLATION; TUMOR VASCULARIZATION; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CHEMISTRY; CHICK EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHICK EMBRYO; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PSEUDOGENES; RATS; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84925499111     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-019-05478-4     Document Type: Erratum

References (36)

1. Perry MM, Tsitsiou E, Austin PJ, Lindsay MA, Gibeon DS, Adcock IM, Chung KF (2014) Role of non-coding RNAs in maintaining primary airway smooth muscle cells. Respir Res 15(1):58
2. Zovoilis A, Mungall AJ, Moore R, Varhol R, Chu A, Wong T, Marra M, Jones SJ (2014) The expression level of small non-coding RNAs derived from the first exon of protein-coding genes is predictive of cancer status. EMBO Rep 15(4):402–410
3. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436(7051):740–744
4. Chen CH, Cheng CY, Chen YC, Sue YM, Liu CT, Cheng TH, Hsu YH, Chen TH (2014) MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis. PLoS One 9(6):e99802
5. Cao M, Li Y, Lu H, Meng Q, Wang L, Cai L, Dong X (2014) miR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells. J Cancer Res Clin Oncol 140(10):1661–1670
6. Ling S, Birnbaum Y, Nanhwan MK, Thomas B, Bajaj M, Ye Y (2013) MicroRNA-dependent cross-talk between VEGF and HIF1alpha in the diabetic retina. Cell Signal 25(12):2840–2847
7. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F et al (2011) Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147(2):344–357
8. Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, Hodges E, Anger M, Sachidanandam R, Schultz RM et al (2008) Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 453(7194):534–538
9. Han YJ, Ma SF, Yourek G, Park YD, Garcia JGN (2011) A transcribed pseudogene of MYLK promotes cell proliferation. FASEB J 25(7):2305–2312
10. Guo X, Tang Y (2011) OCT4 pseudogenes present in human leukemia cells. Clin Exp Med 12(4):207–216
11. Yang J, Li T, Gao C, Lv X, Liu K, Song H, Xing Y, Xi T (2014) FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity. FEBS Lett 588(17):3218–3224
12. Jia J, Yao P, Arif A, Fox PL (2013) Regulation and dysregulation of 3′UTR-mediated translational control. Curr Opin Genet Dev 23(1):29–34
13. Nakagawa Y, Minato M, Sumiyoshi K, Maeda A, Hara C, Murase Y, Nishida T, Kubota S, Takigawa M (2013) Regulation of CCN1 via the 3′-untranslated region. J Cell Commun Signal 7(3):207–217
14. Mercer TR, Wilhelm D, Dinger ME, Solda G, Korbie DJ, Glazov EA, Truong V, Schwenke M, Simons C, Matthaei KI et al (2011) Expression of distinct RNAs from 3′ untranslated regions. Nucleic Acids Res 39(6):2393–2403
15. Swart M, Dandara C (2014) Genetic variation in the 3′-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance. Front Genet 5:167
16. Rutnam ZJ, Du WW, Yang W, Yang X, Yang BB (2014) The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs. Nat Commun 5:2914
17. Rieger MA (2004) Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma. Cancer Res 64(7):2357–2364
18. Yu W, Chai H, Li Y, Zhao H, Xie X, Zheng H, Wang C, Wang X, Yang G, Cai X et al (2012) Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer. Toxicol Appl Pharmacol 264(1):73–83
19. Zheng L, Li X, Gu Y, Ma Y, Xi T (2014) Pseudogene CYP4Z2P 3′UTR promotes angiogenesis in breast cancer. Biochem Biophys Res Commun 453(3):545–551
20. Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK et al (2006) Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma. Clin Cancer Res 12(2):653–661
21. Nicosia RF, Ottinetti A (1990) Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63(1):115–122
22. Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, Chen K, Xiao H, Li H, Tang K et al (2014) Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear cell renal cell carcinoma progression. Mol Cancer Ther 13(12):3086–3097
23. Esposito F, De Martino M, Petti MG, Forzati F, Tornincasa M, Federico A, Arra C, Pierantoni GM, Fusco A (2014) HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget 5(18):8341–8354
24. Li L, Wang D, Xue M, Mi X, Liang Y, Wang P (2014) 3′UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network. Sci Rep 4:5406
25. Ebert MS, Sharp PA (2010) MicroRNA sponges: progress and possibilities. RNA 16(11):2043–2050
26. Brown BD, Naldini L (2009) Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 10(8):578–585
27. Mitrovich QM, Anderson P (2005) mRNA surveillance of expressed pseudogenes in C. elegans. Curr Biol 15(10):963–967
28. Denzler R, Agarwal V, Stefano J, Bartel DP, Stoffel M (2014) Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell 54(5):766–776
29. Figliuzzi M, Marinari E, De Martino A (2013) MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. Biophys J 104(5):1203–1213
30. Ala U, Karreth FA, Bosia C, Pagnani A, Taulli R, Leopold V, Tay Y, Provero P, Zecchina R, Pandolfi PP (2013) Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc Natl Acad Sci USA 110(18):7154–7159
31. Paplomata E, O’Regan R (2014) The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Ther Adv Med Oncol 6(4):154–166
32. Britschgi A, Radimerski T, Bentires-Alj M (2013) Targeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: which combination makes the whole greater than the sum of its parts? Drug Resist Updat 16(3–5):68–72
33. Fu J, Tian C, Xing M, Wang X, Guo H, Sun L, Sun L, Jiang Z, Zhang L (2014) KU004 induces G1 cell cycle arrest in human breast cancer SKBR-3 cells by modulating PI3K/Akt pathway. Biomed Pharmacother 68(5):625–630
34. Marchese FP, Huarte M (2014) Long non-coding RNAs and chromatin modifiers: their place in the epigenetic code. Epigenetics 9(1):21–26
35. Thum T, Fiedler J (2014) LINCing MALAT1 and angiogenesis. Circ Res 114(9):1366–1368
36. Vitiello M, Tuccoli A, Poliseno L (2014) Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol (Dordr)